Ahead of ASCO and BIO, Michael Bailey CEO of AVEO Oncology, discusses the company becoming an LG Chem subsidiary and the future for drug development in the combined entity.
While ESG is still in the early stages for pharma, many companies are moving forward with a need for compliance.
Digital and innovation leader takes issue with the current state of pharma marketing and suggests new approaches are needed.
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
Panel discusses what real-world evidence—and related patient-reporting technology—need to achieve to better influence payer decision-making.
Tool highlights efforts to overcome the challenges of remote disease management in Turkey.